

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | creatine metabolic process (GO:0006600) | 6.79788548 |
| 2 | regulation of actin filament-based movement (GO:1903115) | 6.30870193 |
| 3 | proline biosynthetic process (GO:0006561) | 6.20569495 |
| 4 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.06431940 |
| 5 | cardiac muscle hypertrophy (GO:0003300) | 5.67590570 |
| 6 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.43620572 |
| 7 | response to inactivity (GO:0014854) | 5.42474065 |
| 8 | striated muscle hypertrophy (GO:0014897) | 5.37218521 |
| 9 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.35806344 |
| 10 | transcription from mitochondrial promoter (GO:0006390) | 5.26328046 |
| 11 | cellular response to zinc ion (GO:0071294) | 5.20428984 |
| 12 | DNA deamination (GO:0045006) | 5.18583859 |
| 13 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.10665562 |
| 14 | regulation of cell communication by electrical coupling (GO:0010649) | 5.09080580 |
| 15 | muscle contraction (GO:0006936) | 5.07897201 |
| 16 | adult heart development (GO:0007512) | 5.04765388 |
| 17 | NADH metabolic process (GO:0006734) | 4.96256676 |
| 18 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.94676508 |
| 19 | response to muscle activity (GO:0014850) | 4.90110946 |
| 20 | muscle hypertrophy (GO:0014896) | 4.89311279 |
| 21 | positive regulation of protein homooligomerization (GO:0032464) | 4.85321549 |
| 22 | regulation of the force of heart contraction (GO:0002026) | 4.75324417 |
| 23 | muscle tissue morphogenesis (GO:0060415) | 4.73983688 |
| 24 | actin-myosin filament sliding (GO:0033275) | 4.72163636 |
| 25 | muscle filament sliding (GO:0030049) | 4.72163636 |
| 26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.65304099 |
| 27 | embryonic process involved in female pregnancy (GO:0060136) | 4.62622687 |
| 28 | muscle system process (GO:0003012) | 4.59376475 |
| 29 | regulation of striated muscle contraction (GO:0006942) | 4.54729140 |
| 30 | sarcomere organization (GO:0045214) | 4.49151611 |
| 31 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.36306681 |
| 32 | replication fork processing (GO:0031297) | 4.28467292 |
| 33 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.23208106 |
| 34 | striated muscle adaptation (GO:0014888) | 4.20993610 |
| 35 | muscle hypertrophy in response to stress (GO:0003299) | 4.17164154 |
| 36 | cardiac muscle adaptation (GO:0014887) | 4.17164154 |
| 37 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.17164154 |
| 38 | skeletal muscle fiber development (GO:0048741) | 4.10619431 |
| 39 | proline metabolic process (GO:0006560) | 4.05272789 |
| 40 | 2-oxoglutarate metabolic process (GO:0006103) | 4.04032820 |
| 41 | heart process (GO:0003015) | 4.00378967 |
| 42 | heart contraction (GO:0060047) | 4.00378967 |
| 43 | regulation of skeletal muscle contraction (GO:0014819) | 4.00285863 |
| 44 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.00033912 |
| 45 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.98427790 |
| 46 | oxidative demethylation (GO:0070989) | 3.92023279 |
| 47 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.89085154 |
| 48 | regulation of membrane repolarization (GO:0060306) | 3.84189737 |
| 49 | myotube cell development (GO:0014904) | 3.78065749 |
| 50 | skeletal muscle contraction (GO:0003009) | 3.76426245 |
| 51 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.74152905 |
| 52 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.74152905 |
| 53 | muscle fiber development (GO:0048747) | 3.73894449 |
| 54 | myofibril assembly (GO:0030239) | 3.73727197 |
| 55 | dosage compensation (GO:0007549) | 3.70573870 |
| 56 | cardiac myofibril assembly (GO:0055003) | 3.69544412 |
| 57 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.69498143 |
| 58 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.68642663 |
| 59 | regulation of integrin activation (GO:0033623) | 3.68496897 |
| 60 | glucan catabolic process (GO:0009251) | 3.67843895 |
| 61 | tricarboxylic acid cycle (GO:0006099) | 3.66848034 |
| 62 | regulation of protein homooligomerization (GO:0032462) | 3.66167526 |
| 63 | regulation of ATPase activity (GO:0043462) | 3.61187884 |
| 64 | regulation of ATP catabolic process (GO:1903289) | 3.61187884 |
| 65 | mitochondrial DNA metabolic process (GO:0032042) | 3.60757487 |
| 66 | glucan biosynthetic process (GO:0009250) | 3.60726006 |
| 67 | glycogen biosynthetic process (GO:0005978) | 3.60726006 |
| 68 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.58280007 |
| 69 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.57974681 |
| 70 | actin-mediated cell contraction (GO:0070252) | 3.57757641 |
| 71 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.55819708 |
| 72 | muscle adaptation (GO:0043500) | 3.51806056 |
| 73 | heme biosynthetic process (GO:0006783) | 3.49783717 |
| 74 | regulation of translational fidelity (GO:0006450) | 3.46779092 |
| 75 | cardiac muscle contraction (GO:0060048) | 3.46526582 |
| 76 | cellular polysaccharide catabolic process (GO:0044247) | 3.44841630 |
| 77 | striated muscle cell development (GO:0055002) | 3.40103461 |
| 78 | skeletal muscle tissue development (GO:0007519) | 3.39895514 |
| 79 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.39650519 |
| 80 | regulation of muscle contraction (GO:0006937) | 3.39156718 |
| 81 | negative regulation of necroptotic process (GO:0060546) | 3.37940358 |
| 82 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.34871588 |
| 83 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.34140735 |
| 84 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.32630632 |
| 85 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.32630632 |
| 86 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.32459755 |
| 87 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.32459755 |
| 88 | oxidative phosphorylation (GO:0006119) | 3.32247467 |
| 89 | G1 DNA damage checkpoint (GO:0044783) | 3.30384215 |
| 90 | regulation of muscle system process (GO:0090257) | 3.29113347 |
| 91 | regulation of heart rate (GO:0002027) | 3.27995861 |
| 92 | oxaloacetate metabolic process (GO:0006107) | 3.26613229 |
| 93 | negative regulation of RNA splicing (GO:0033119) | 3.25816770 |
| 94 | apoptotic process involved in morphogenesis (GO:0060561) | 3.25697428 |
| 95 | fatty acid transmembrane transport (GO:1902001) | 3.23647178 |
| 96 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.22512094 |
| 97 | negative regulation of potassium ion transport (GO:0043267) | 3.22223200 |
| 98 | relaxation of cardiac muscle (GO:0055119) | 3.21572700 |
| 99 | mitotic G1/S transition checkpoint (GO:0044819) | 3.19715192 |
| 100 | base-excision repair (GO:0006284) | 3.18991494 |
| 101 | regulation of sequestering of triglyceride (GO:0010889) | 3.18837875 |
| 102 | negative regulation of mRNA processing (GO:0050686) | 3.18582900 |
| 103 | positive regulation by host of viral transcription (GO:0043923) | 3.18265501 |
| 104 | cardiac ventricle formation (GO:0003211) | 3.18204386 |
| 105 | positive regulation of cation channel activity (GO:2001259) | 3.17266909 |
| 106 | regulation of heart contraction (GO:0008016) | 3.17064998 |
| 107 | striated muscle contraction (GO:0006941) | 3.17046142 |
| 108 | muscle cell cellular homeostasis (GO:0046716) | 3.16669631 |
| 109 | mitochondrial genome maintenance (GO:0000002) | 3.16338524 |
| 110 | cardiac chamber formation (GO:0003207) | 3.16243751 |
| 111 | formation of translation preinitiation complex (GO:0001731) | 3.14844020 |
| 112 | striated muscle atrophy (GO:0014891) | 3.14474274 |
| 113 | positive regulation of lamellipodium assembly (GO:0010592) | 3.11180712 |
| 114 | cardiac muscle cell development (GO:0055013) | 3.10972864 |
| 115 | succinate metabolic process (GO:0006105) | 3.09842564 |
| 116 | glycogen metabolic process (GO:0005977) | 3.09706311 |
| 117 | mitochondrial fusion (GO:0008053) | 3.06505722 |
| 118 | negative regulation of stress fiber assembly (GO:0051497) | 3.06265847 |
| 119 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.05936889 |
| 120 | polysaccharide catabolic process (GO:0000272) | 3.05639013 |
| 121 | positive regulation of protein oligomerization (GO:0032461) | 3.05550230 |
| 122 | gluconeogenesis (GO:0006094) | 3.05454855 |
| 123 | glucan metabolic process (GO:0044042) | 3.04607337 |
| 124 | cellular glucan metabolic process (GO:0006073) | 3.04607337 |
| 125 | establishment of apical/basal cell polarity (GO:0035089) | 3.03443075 |
| 126 | carnitine shuttle (GO:0006853) | 3.02733178 |
| 127 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.02484265 |
| 128 | viral mRNA export from host cell nucleus (GO:0046784) | 3.02209061 |
| 129 | mRNA cleavage (GO:0006379) | 3.00605265 |
| 130 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.00214455 |
| 131 | tetrapyrrole biosynthetic process (GO:0033014) | 2.99277376 |
| 132 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.97451703 |
| 133 | viral transcription (GO:0019083) | 2.97153795 |
| 134 | B cell receptor signaling pathway (GO:0050853) | 2.96073937 |
| 135 | skeletal muscle adaptation (GO:0043501) | 2.94286956 |
| 136 | plasma membrane repair (GO:0001778) | 2.93797740 |
| 137 | embryonic placenta development (GO:0001892) | 2.93263709 |
| 138 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.92058871 |
| 139 | positive regulation of B cell differentiation (GO:0045579) | 2.91863702 |
| 140 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.91726771 |
| 141 | cardiac cell development (GO:0055006) | 2.90777861 |
| 142 | oxygen transport (GO:0015671) | 2.88526191 |
| 143 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.88246057 |
| 144 | regulation of relaxation of muscle (GO:1901077) | 2.87758709 |
| 145 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.85539137 |
| 146 | actin filament-based movement (GO:0030048) | 2.84314388 |
| 147 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.83863282 |
| 148 | positive regulation of myotube differentiation (GO:0010831) | 2.82882698 |
| 149 | DNA demethylation (GO:0080111) | 2.82643670 |
| 150 | erythrocyte maturation (GO:0043249) | 2.80916507 |
| 151 | DNA strand elongation (GO:0022616) | 2.80476388 |
| 152 | DNA strand renaturation (GO:0000733) | 2.80047954 |
| 153 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.78520710 |
| 154 | DNA topological change (GO:0006265) | 2.78009330 |
| 155 | mitochondrial RNA metabolic process (GO:0000959) | 2.77309866 |
| 156 | telomere maintenance via recombination (GO:0000722) | 2.77268183 |
| 157 | actomyosin structure organization (GO:0031032) | 2.72855746 |
| 158 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.71903924 |
| 159 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.71727452 |
| 160 | translational termination (GO:0006415) | 2.71008410 |
| 161 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.70154736 |
| 162 | retinoic acid receptor signaling pathway (GO:0048384) | 2.69518688 |
| 163 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.69173803 |
| 164 | translational elongation (GO:0006414) | 2.68964882 |
| 165 | negative regulation of mRNA metabolic process (GO:1903312) | 2.65870196 |
| 166 | glycogen catabolic process (GO:0005980) | 2.65788586 |
| 167 | V(D)J recombination (GO:0033151) | 2.61963720 |
| 168 | regulation of protein oligomerization (GO:0032459) | 2.60666159 |
| 169 | negative regulation of cell cycle arrest (GO:0071157) | 2.58014102 |
| 170 | termination of RNA polymerase II transcription (GO:0006369) | 2.57747600 |
| 171 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.53768311 |
| 172 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.53048336 |
| 173 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.53048336 |
| 174 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52413878 |
| 175 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.52313696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.44347835 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.74760978 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.57788077 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.55647928 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.51928124 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.40490997 |
| 7 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.90135476 |
| 8 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.90135476 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.39413960 |
| 10 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.36929095 |
| 11 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20705955 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15313892 |
| 13 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.11815780 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.06488072 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04456859 |
| 16 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.02857754 |
| 17 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.02225216 |
| 18 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.02211486 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.00537549 |
| 20 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00121174 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.95218291 |
| 22 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.92072002 |
| 23 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.87519214 |
| 24 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86925506 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85080651 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84790910 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84511235 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83779198 |
| 29 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.83408455 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82091467 |
| 31 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81855576 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79686710 |
| 33 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78533174 |
| 34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.71556015 |
| 35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.71304937 |
| 36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70484651 |
| 37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66906673 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66137233 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64882905 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.64228977 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.62821981 |
| 42 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.62627205 |
| 43 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.60032811 |
| 44 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59348598 |
| 45 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.56268994 |
| 46 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.56163750 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.55408703 |
| 48 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.55218553 |
| 49 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54932767 |
| 50 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54854431 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.52461211 |
| 52 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51711943 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50183568 |
| 54 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.49071835 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48636818 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.48357417 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46627453 |
| 58 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.46517656 |
| 59 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.45859683 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.45597215 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44790482 |
| 62 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.44619484 |
| 63 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.43808499 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43006574 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.42747389 |
| 66 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41676665 |
| 67 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41139596 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38998584 |
| 69 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36049763 |
| 70 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35971767 |
| 71 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.35780840 |
| 72 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33853804 |
| 73 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33771117 |
| 74 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.32621293 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.31437554 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31249225 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31227786 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.30422233 |
| 79 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30317640 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.29354451 |
| 81 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.28743486 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27155116 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26733995 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26435561 |
| 85 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.26293628 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25955791 |
| 87 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25075273 |
| 88 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.25009581 |
| 89 | SA1_27219007_Chip-Seq_Bcells_Human | 1.24996892 |
| 90 | MYB_26560356_Chip-Seq_TH1_Human | 1.24639031 |
| 91 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.24254415 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24225506 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23657521 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22587167 |
| 95 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.21681267 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21514485 |
| 97 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.20069700 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.19520750 |
| 99 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.19275733 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19177201 |
| 101 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.18590137 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17828235 |
| 103 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.17585961 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17577552 |
| 105 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16515693 |
| 106 | GATA1_19941826_ChIP-Seq_K562_Human | 1.15791288 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15661984 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15185246 |
| 109 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14885522 |
| 110 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12771963 |
| 111 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.12675602 |
| 112 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.12515882 |
| 113 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.12353377 |
| 114 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.11030416 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10946935 |
| 116 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10664262 |
| 117 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.10625398 |
| 118 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.10551796 |
| 119 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10098855 |
| 120 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09371659 |
| 121 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09102894 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08830515 |
| 123 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.08710238 |
| 124 | MYB_26560356_Chip-Seq_TH2_Human | 1.08616544 |
| 125 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.08086799 |
| 126 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07846976 |
| 127 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07711873 |
| 128 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07258685 |
| 129 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06879364 |
| 130 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06622100 |
| 131 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.06450982 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.06175657 |
| 133 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.05212108 |
| 134 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05007018 |
| 135 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04577058 |
| 136 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04314735 |
| 137 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.03710217 |
| 138 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03120786 |
| 139 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03070097 |
| 140 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.02722652 |
| 141 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02589146 |
| 142 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02183071 |
| 143 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01958274 |
| 144 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00831637 |
| 145 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.00456674 |
| 146 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98830005 |
| 147 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98798916 |
| 148 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98266414 |
| 149 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98151101 |
| 150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98092474 |
| 151 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.97880091 |
| 152 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97811152 |
| 153 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.97709724 |
| 154 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.97154553 |
| 155 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97006614 |
| 156 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96627663 |
| 157 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96487531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.23138012 |
| 2 | MP0000751_myopathy | 3.66597337 |
| 3 | MP0005451_abnormal_body_composition | 3.17231710 |
| 4 | MP0009278_abnormal_bone_marrow | 3.12067176 |
| 5 | MP0000749_muscle_degeneration | 3.01830880 |
| 6 | MP0004233_abnormal_muscle_weight | 2.98852744 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.96647224 |
| 8 | MP0008057_abnormal_DNA_replication | 2.88188799 |
| 9 | MP0005330_cardiomyopathy | 2.69642250 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.67498237 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.56304926 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.45901263 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.42932874 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.40733295 |
| 15 | MP0002269_muscular_atrophy | 2.39947277 |
| 16 | MP0002106_abnormal_muscle_physiology | 2.39300690 |
| 17 | MP0000685_abnormal_immune_system | 2.21697879 |
| 18 | MP0006138_congestive_heart_failure | 2.13510121 |
| 19 | MP0001545_abnormal_hematopoietic_system | 2.13429916 |
| 20 | MP0005397_hematopoietic_system_phenotyp | 2.13429916 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.12564206 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.05003268 |
| 23 | MP0000759_abnormal_skeletal_muscle | 2.01284648 |
| 24 | MP0000747_muscle_weakness | 2.00320428 |
| 25 | MP0004215_abnormal_myocardial_fiber | 1.98035263 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.95595692 |
| 27 | MP0003828_pulmonary_edema | 1.95296241 |
| 28 | MP0004130_abnormal_muscle_cell | 1.87829235 |
| 29 | MP0005369_muscle_phenotype | 1.84183240 |
| 30 | MP0010094_abnormal_chromosome_stability | 1.71863558 |
| 31 | MP0006036_abnormal_mitochondrial_physio | 1.61837938 |
| 32 | MP0003763_abnormal_thymus_physiology | 1.61605425 |
| 33 | MP0008775_abnormal_heart_ventricle | 1.58246471 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.57965972 |
| 35 | MP0003137_abnormal_impulse_conducting | 1.57163184 |
| 36 | MP0008995_early_reproductive_senescence | 1.55399401 |
| 37 | MP0002398_abnormal_bone_marrow | 1.51902424 |
| 38 | MP0005620_abnormal_muscle_contractility | 1.51066129 |
| 39 | MP0003567_abnormal_fetal_cardiomyocyte | 1.47399903 |
| 40 | MP0005670_abnormal_white_adipose | 1.47373860 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.45670724 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.43665467 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.43283448 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.40168823 |
| 45 | MP0004085_abnormal_heartbeat | 1.38432427 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.38337743 |
| 47 | MP0001800_abnormal_humoral_immune | 1.33389703 |
| 48 | MP0003111_abnormal_nucleus_morphology | 1.32389672 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.26876203 |
| 50 | MP0002722_abnormal_immune_system | 1.26851527 |
| 51 | MP0001544_abnormal_cardiovascular_syste | 1.26310227 |
| 52 | MP0005385_cardiovascular_system_phenoty | 1.26310227 |
| 53 | MP0004147_increased_porphyrin_level | 1.26265429 |
| 54 | MP0000490_abnormal_crypts_of | 1.26163578 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.22936911 |
| 56 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22446669 |
| 57 | MP0003077_abnormal_cell_cycle | 1.21998033 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.21268374 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.18702397 |
| 60 | MP0002972_abnormal_cardiac_muscle | 1.15649999 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.14330358 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.11499221 |
| 63 | MP0002009_preneoplasia | 1.11057810 |
| 64 | MP0002405_respiratory_system_inflammati | 1.10800265 |
| 65 | MP0004957_abnormal_blastocyst_morpholog | 1.10539650 |
| 66 | MP0009333_abnormal_splenocyte_physiolog | 1.07832717 |
| 67 | MP0005375_adipose_tissue_phenotype | 1.06595255 |
| 68 | MP0002429_abnormal_blood_cell | 1.05668790 |
| 69 | MP0000266_abnormal_heart_morphology | 1.04999676 |
| 70 | MP0008058_abnormal_DNA_repair | 1.04666648 |
| 71 | MP0000716_abnormal_immune_system | 1.04344015 |
| 72 | MP0001790_abnormal_immune_system | 1.04336344 |
| 73 | MP0005387_immune_system_phenotype | 1.04336344 |
| 74 | MP0004484_altered_response_of | 1.02222314 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 1.01488208 |
| 76 | MP0004185_abnormal_adipocyte_glucose | 1.00149502 |
| 77 | MP0000003_abnormal_adipose_tissue | 1.00139477 |
| 78 | MP0003786_premature_aging | 1.00092030 |
| 79 | MP0001835_abnormal_antigen_presentation | 0.97867079 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.97129970 |
| 81 | MP0005174_abnormal_tail_pigmentation | 0.94039615 |
| 82 | MP0005165_increased_susceptibility_to | 0.93206477 |
| 83 | MP0005266_abnormal_metabolism | 0.92314641 |
| 84 | MP0002452_abnormal_antigen_presenting | 0.90635637 |
| 85 | MP0000733_abnormal_muscle_development | 0.90166059 |
| 86 | MP0002971_abnormal_brown_adipose | 0.89107367 |
| 87 | MP0000350_abnormal_cell_proliferation | 0.89056149 |
| 88 | MP0002086_abnormal_extraembryonic_tissu | 0.88214399 |
| 89 | MP0004510_myositis | 0.88069097 |
| 90 | MP0002420_abnormal_adaptive_immunity | 0.87944822 |
| 91 | MP0001697_abnormal_embryo_size | 0.87772112 |
| 92 | MP0000343_altered_response_to | 0.85872522 |
| 93 | MP0000313_abnormal_cell_death | 0.85138952 |
| 94 | MP0005666_abnormal_adipose_tissue | 0.84701556 |
| 95 | MP0001819_abnormal_immune_cell | 0.84378015 |
| 96 | MP0003045_fibrosis | 0.82720855 |
| 97 | MP0001661_extended_life_span | 0.82599159 |
| 98 | MP0001879_abnormal_lymphatic_vessel | 0.81887754 |
| 99 | MP0004197_abnormal_fetal_growth/weight/ | 0.81213433 |
| 100 | MP0003984_embryonic_growth_retardation | 0.80502449 |
| 101 | MP0001672_abnormal_embryogenesis/_devel | 0.77854230 |
| 102 | MP0005380_embryogenesis_phenotype | 0.77854230 |
| 103 | MP0004270_analgesia | 0.77133183 |
| 104 | MP0001873_stomach_inflammation | 0.76985314 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.76840541 |
| 106 | MP0002723_abnormal_immune_serum | 0.76631216 |
| 107 | MP0003693_abnormal_embryo_hatching | 0.75862898 |
| 108 | MP0002080_prenatal_lethality | 0.75680360 |
| 109 | MP0010307_abnormal_tumor_latency | 0.75642535 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.75205385 |
| 111 | MP0002088_abnormal_embryonic_growth/wei | 0.75142592 |
| 112 | MP0005464_abnormal_platelet_physiology | 0.74081693 |
| 113 | MP0001730_embryonic_growth_arrest | 0.73808408 |
| 114 | MP0003303_peritoneal_inflammation | 0.73315439 |
| 115 | MP0001784_abnormal_fluid_regulation | 0.72933019 |
| 116 | MP0003724_increased_susceptibility_to | 0.67206730 |
| 117 | MP0002128_abnormal_blood_circulation | 0.67059510 |
| 118 | MP0002822_catalepsy | 0.58607059 |
| 119 | MP0005535_abnormal_body_temperature | 0.55358992 |
| 120 | MP0002078_abnormal_glucose_homeostasis | 0.54655194 |
| 121 | MP0003279_aneurysm | 0.52666805 |
| 122 | MP0003879_abnormal_hair_cell | 0.52547822 |
| 123 | MP0008569_lethality_at_weaning | 0.51702092 |
| 124 | MP0003948_abnormal_gas_homeostasis | 0.45827350 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.42532814 |
| 126 | MP0008874_decreased_physiological_sensi | 0.40598276 |
| 127 | MP0002933_joint_inflammation | 0.40501822 |
| 128 | MP0000230_abnormal_systemic_arterial | 0.40057308 |
| 129 | MP0002638_abnormal_pupillary_reflex | 0.38995509 |
| 130 | MP0009840_abnormal_foam_cell | 0.38622927 |
| 131 | MP0000249_abnormal_blood_vessel | 0.37028214 |
| 132 | MP0000372_irregular_coat_pigmentation | 0.36961486 |
| 133 | MP0008260_abnormal_autophagy | 0.36888334 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.36078673 |
| 135 | MP0002138_abnormal_hepatobiliary_system | 0.34991957 |
| 136 | MP0005409_darkened_coat_color | 0.34460941 |
| 137 | MP0005083_abnormal_biliary_tract | 0.34056367 |
| 138 | MP0009780_abnormal_chondrocyte_physiolo | 0.33289563 |
| 139 | MP0005334_abnormal_fat_pad | 0.32953988 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.32472586 |
| 141 | MP0005166_decreased_susceptibility_to | 0.30972642 |
| 142 | MP0006035_abnormal_mitochondrial_morpho | 0.30454187 |
| 143 | MP0002925_abnormal_cardiovascular_devel | 0.29052692 |
| 144 | MP0001614_abnormal_blood_vessel | 0.26789565 |
| 145 | MP0005319_abnormal_enzyme/_coenzyme | 0.26395215 |
| 146 | MP0005376_homeostasis/metabolism_phenot | 0.23720460 |
| 147 | MP0009115_abnormal_fat_cell | 0.23284245 |
| 148 | MP0005452_abnormal_adipose_tissue | 0.20787716 |
| 149 | MP0003705_abnormal_hypodermis_morpholog | 0.20229451 |
| 150 | MP0003300_gastrointestinal_ulcer | 0.19781102 |
| 151 | MP0008004_abnormal_stomach_pH | 0.18256259 |
| 152 | MP0009672_abnormal_birth_weight | 0.18237796 |
| 153 | MP0001943_abnormal_respiration | 0.18212321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.25557161 |
| 2 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 5.20345414 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 4.92079043 |
| 4 | Bundle branch block (HP:0011710) | 4.65365928 |
| 5 | Distal lower limb muscle weakness (HP:0009053) | 4.41604610 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.31370382 |
| 7 | Sudden death (HP:0001699) | 4.29052693 |
| 8 | Myoglobinuria (HP:0002913) | 4.26879614 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.26538766 |
| 10 | Rimmed vacuoles (HP:0003805) | 4.17432898 |
| 11 | Muscle fiber inclusion bodies (HP:0100299) | 4.05228143 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 3.95213340 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.88307145 |
| 14 | Increased variability in muscle fiber diameter (HP:0003557) | 3.83168844 |
| 15 | Subaortic stenosis (HP:0001682) | 3.81003870 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.81003870 |
| 17 | Ventricular tachycardia (HP:0004756) | 3.70264552 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.57864754 |
| 19 | Pustule (HP:0200039) | 3.37170187 |
| 20 | Nemaline bodies (HP:0003798) | 3.32141403 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 3.28817911 |
| 22 | Rhabdomyolysis (HP:0003201) | 3.25742587 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 3.17787466 |
| 24 | Agammaglobulinemia (HP:0004432) | 3.12420628 |
| 25 | Myotonia (HP:0002486) | 3.10826412 |
| 26 | Poikiloderma (HP:0001029) | 3.09358646 |
| 27 | Difficulty running (HP:0009046) | 3.09033652 |
| 28 | Colitis (HP:0002583) | 3.06812658 |
| 29 | Heart block (HP:0012722) | 3.06306007 |
| 30 | Increased connective tissue (HP:0009025) | 3.03433213 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 3.01810377 |
| 32 | Abnormality of the calf musculature (HP:0001430) | 3.01395451 |
| 33 | Polycythemia (HP:0001901) | 2.96690017 |
| 34 | Distal lower limb amyotrophy (HP:0008944) | 2.95689283 |
| 35 | Distal arthrogryposis (HP:0005684) | 2.93482069 |
| 36 | Round ear (HP:0100830) | 2.93211880 |
| 37 | Frequent falls (HP:0002359) | 2.91762200 |
| 38 | Generalized muscle weakness (HP:0003324) | 2.90322485 |
| 39 | Abnormal atrioventricular conduction (HP:0005150) | 2.89161070 |
| 40 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.87515476 |
| 41 | Muscle stiffness (HP:0003552) | 2.83429060 |
| 42 | Papilloma (HP:0012740) | 2.82666775 |
| 43 | Verrucae (HP:0200043) | 2.82666775 |
| 44 | Myopathic facies (HP:0002058) | 2.81988049 |
| 45 | Ulnar deviation of the wrist (HP:0003049) | 2.81649815 |
| 46 | Ragged-red muscle fibers (HP:0003200) | 2.80628264 |
| 47 | Large for gestational age (HP:0001520) | 2.80135152 |
| 48 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.79500116 |
| 49 | Lipoatrophy (HP:0100578) | 2.79012292 |
| 50 | Syncope (HP:0001279) | 2.77611402 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.77394209 |
| 52 | Calcaneovalgus deformity (HP:0001848) | 2.72274315 |
| 53 | Abnormality of the foot musculature (HP:0001436) | 2.69714430 |
| 54 | Cellulitis (HP:0100658) | 2.66806699 |
| 55 | Difficulty climbing stairs (HP:0003551) | 2.65865163 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.64646592 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.62016293 |
| 58 | Ulnar bowing (HP:0003031) | 2.61928600 |
| 59 | Atrial fibrillation (HP:0005110) | 2.61371824 |
| 60 | Absent phalangeal crease (HP:0006109) | 2.60499627 |
| 61 | Ventricular fibrillation (HP:0001663) | 2.59605045 |
| 62 | Basal cell carcinoma (HP:0002671) | 2.58909656 |
| 63 | Neck muscle weakness (HP:0000467) | 2.57899308 |
| 64 | Hypochromic anemia (HP:0001931) | 2.57053894 |
| 65 | Supraventricular tachycardia (HP:0004755) | 2.54423513 |
| 66 | Areflexia of lower limbs (HP:0002522) | 2.54256399 |
| 67 | Primary atrial arrhythmia (HP:0001692) | 2.52081961 |
| 68 | Diaphragmatic weakness (HP:0009113) | 2.49674863 |
| 69 | Supraventricular arrhythmia (HP:0005115) | 2.49120011 |
| 70 | Annular pancreas (HP:0001734) | 2.47907306 |
| 71 | IgM deficiency (HP:0002850) | 2.46578591 |
| 72 | Scapular winging (HP:0003691) | 2.45168335 |
| 73 | Bulbar palsy (HP:0001283) | 2.41924504 |
| 74 | Foot dorsiflexor weakness (HP:0009027) | 2.39815406 |
| 75 | Deformed tarsal bones (HP:0008119) | 2.39807751 |
| 76 | Recurrent bronchitis (HP:0002837) | 2.37253373 |
| 77 | Rib fusion (HP:0000902) | 2.30634827 |
| 78 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.29528330 |
| 79 | Atrioventricular block (HP:0001678) | 2.27186837 |
| 80 | Right ventricular cardiomyopathy (HP:0011663) | 2.27055872 |
| 81 | Abnormal number of erythroid precursors (HP:0012131) | 2.26112173 |
| 82 | EMG: neuropathic changes (HP:0003445) | 2.24760139 |
| 83 | Muscle fiber atrophy (HP:0100295) | 2.22011026 |
| 84 | Limb-girdle muscle atrophy (HP:0003797) | 2.21757298 |
| 85 | Congenital hip dislocation (HP:0001374) | 2.21451631 |
| 86 | Dilated cardiomyopathy (HP:0001644) | 2.19697416 |
| 87 | Progressive muscle weakness (HP:0003323) | 2.16253318 |
| 88 | Lower limb amyotrophy (HP:0007210) | 2.14771658 |
| 89 | Poikilocytosis (HP:0004447) | 2.14565393 |
| 90 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.12393794 |
| 91 | Muscle fibrillation (HP:0010546) | 2.11422010 |
| 92 | Albinism (HP:0001022) | 2.10531727 |
| 93 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.09252125 |
| 94 | Malignant hyperthermia (HP:0002047) | 2.09040291 |
| 95 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08988593 |
| 96 | IgA deficiency (HP:0002720) | 2.08479288 |
| 97 | Prolonged QT interval (HP:0001657) | 2.07858920 |
| 98 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.07630480 |
| 99 | Muscular dystrophy (HP:0003560) | 2.07529535 |
| 100 | Gowers sign (HP:0003391) | 2.06581780 |
| 101 | Panhypogammaglobulinemia (HP:0003139) | 2.06164049 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 2.04797881 |
| 103 | Cerebral aneurysm (HP:0004944) | 2.04422678 |
| 104 | Increased IgM level (HP:0003496) | 2.03691038 |
| 105 | Abnormal finger flexion creases (HP:0006143) | 2.03241071 |
| 106 | Intestinal fistula (HP:0100819) | 2.02599062 |
| 107 | Abnormal EKG (HP:0003115) | 2.02295500 |
| 108 | Slender build (HP:0001533) | 1.99022212 |
| 109 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.98230890 |
| 110 | Type 2 muscle fiber atrophy (HP:0003554) | 1.97206574 |
| 111 | Easy fatigability (HP:0003388) | 1.96504568 |
| 112 | Abnormality of the neuromuscular junction (HP:0003398) | 1.96492681 |
| 113 | Fatigable weakness (HP:0003473) | 1.96492681 |
| 114 | Abnormality of the nasal mucosa (HP:0000433) | 1.95500259 |
| 115 | Palpitations (HP:0001962) | 1.95443684 |
| 116 | Spinal rigidity (HP:0003306) | 1.94344106 |
| 117 | Acute lymphatic leukemia (HP:0006721) | 1.92250879 |
| 118 | Waddling gait (HP:0002515) | 1.92180317 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.91718069 |
| 120 | Paralysis (HP:0003470) | 1.91050277 |
| 121 | Squamous cell carcinoma (HP:0002860) | 1.90623061 |
| 122 | Hip contracture (HP:0003273) | 1.88439948 |
| 123 | Hyperkalemia (HP:0002153) | 1.86228593 |
| 124 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.85015553 |
| 125 | Hypoplastic ischia (HP:0003175) | 1.84173869 |
| 126 | Proximal amyotrophy (HP:0007126) | 1.82858628 |
| 127 | Abnormality of the fingertips (HP:0001211) | 1.82369743 |
| 128 | Weak cry (HP:0001612) | 1.82327064 |
| 129 | Ventricular arrhythmia (HP:0004308) | 1.80893560 |
| 130 | Rectal fistula (HP:0100590) | 1.80794619 |
| 131 | Rectovaginal fistula (HP:0000143) | 1.80794619 |
| 132 | Microcytic anemia (HP:0001935) | 1.80058046 |
| 133 | Abnormality of the calcaneus (HP:0008364) | 1.79988023 |
| 134 | Left ventricular hypertrophy (HP:0001712) | 1.79577728 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.75722356 |
| 136 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74665141 |
| 137 | Increased muscle lipid content (HP:0009058) | 1.73515185 |
| 138 | Exercise intolerance (HP:0003546) | 1.72816894 |
| 139 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.71237371 |
| 140 | Steppage gait (HP:0003376) | 1.65227337 |
| 141 | Sudden cardiac death (HP:0001645) | 1.56075240 |
| 142 | Limb-girdle muscle weakness (HP:0003325) | 1.47450384 |
| 143 | Palmoplantar keratoderma (HP:0000982) | 1.46480739 |
| 144 | Abnormality of the tricuspid valve (HP:0001702) | 1.45619937 |
| 145 | Dysmetric saccades (HP:0000641) | 1.45531975 |
| 146 | Abnormality of the endocardium (HP:0004306) | 1.44445961 |
| 147 | Facial diplegia (HP:0001349) | 1.43296480 |
| 148 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.37305897 |
| 149 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.37305897 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 3.97574131 |
| 2 | ICK | 3.62617197 |
| 3 | TTN | 2.98241828 |
| 4 | MAP4K1 | 2.77639005 |
| 5 | MAP3K11 | 2.69231013 |
| 6 | PHKG1 | 2.65182032 |
| 7 | PHKG2 | 2.65182032 |
| 8 | PINK1 | 2.64470349 |
| 9 | TRIB3 | 2.62159421 |
| 10 | EEF2K | 2.60583081 |
| 11 | MAP3K6 | 2.47273102 |
| 12 | MAPK15 | 2.25118604 |
| 13 | OBSCN | 2.15516082 |
| 14 | PKN2 | 1.97368064 |
| 15 | DDR2 | 1.89204519 |
| 16 | PIM2 | 1.86578611 |
| 17 | PRKD2 | 1.71394199 |
| 18 | MATK | 1.70219675 |
| 19 | MAP2K3 | 1.55139449 |
| 20 | ERN1 | 1.52862951 |
| 21 | FLT3 | 1.51720719 |
| 22 | MAPKAPK3 | 1.49734574 |
| 23 | DYRK1B | 1.49198957 |
| 24 | TRPM7 | 1.48965793 |
| 25 | MAPK11 | 1.46403392 |
| 26 | CSK | 1.37175835 |
| 27 | EPHB1 | 1.33237231 |
| 28 | PIM1 | 1.32710681 |
| 29 | DMPK | 1.28046492 |
| 30 | FGR | 1.25016296 |
| 31 | RPS6KC1 | 1.18678465 |
| 32 | RPS6KL1 | 1.18678465 |
| 33 | PRPF4B | 1.17336324 |
| 34 | EPHA3 | 1.16288353 |
| 35 | RPS6KB2 | 1.14276070 |
| 36 | PDGFRA | 1.11193133 |
| 37 | UHMK1 | 1.10789281 |
| 38 | RPS6KA6 | 1.10661748 |
| 39 | DAPK1 | 1.09122018 |
| 40 | DYRK3 | 1.06321191 |
| 41 | BMX | 1.05302298 |
| 42 | MAPK12 | 1.05274194 |
| 43 | MAP2K6 | 1.05176277 |
| 44 | MAP3K13 | 1.03809367 |
| 45 | BTK | 1.01949601 |
| 46 | CDK7 | 1.01838999 |
| 47 | SIK2 | 1.00994046 |
| 48 | KSR2 | 1.00636870 |
| 49 | NEK1 | 1.00119230 |
| 50 | CDC42BPA | 0.99437702 |
| 51 | TYRO3 | 0.98868889 |
| 52 | TGFBR2 | 0.97939183 |
| 53 | CDK12 | 0.95570727 |
| 54 | SYK | 0.93279279 |
| 55 | GRK6 | 0.92780651 |
| 56 | MAP2K4 | 0.91346703 |
| 57 | STK4 | 0.90901893 |
| 58 | NME2 | 0.90625182 |
| 59 | HIPK2 | 0.89707505 |
| 60 | TIE1 | 0.89317996 |
| 61 | MAP3K7 | 0.88993917 |
| 62 | STK10 | 0.88920323 |
| 63 | FGFR4 | 0.88841610 |
| 64 | MAPK7 | 0.88327645 |
| 65 | NEK2 | 0.85923511 |
| 66 | CSF1R | 0.85800525 |
| 67 | TAOK1 | 0.84763549 |
| 68 | CDK4 | 0.84714467 |
| 69 | CAMK4 | 0.84175607 |
| 70 | MARK1 | 0.82595542 |
| 71 | LRRK2 | 0.82073331 |
| 72 | PRKAA1 | 0.81987157 |
| 73 | MARK2 | 0.81358324 |
| 74 | TAOK2 | 0.81080672 |
| 75 | CDK6 | 0.79219089 |
| 76 | MAP3K1 | 0.78671206 |
| 77 | STK24 | 0.77585189 |
| 78 | RIPK4 | 0.77269780 |
| 79 | BCKDK | 0.76244290 |
| 80 | KDR | 0.74943497 |
| 81 | ZAP70 | 0.69491878 |
| 82 | MYLK | 0.68475004 |
| 83 | KIT | 0.65328948 |
| 84 | PRKD1 | 0.65235425 |
| 85 | LYN | 0.64699102 |
| 86 | NEK9 | 0.63987472 |
| 87 | CAMK2D | 0.63566224 |
| 88 | MAPK4 | 0.62243221 |
| 89 | YES1 | 0.62229732 |
| 90 | CAMK1 | 0.61923090 |
| 91 | CAMK2G | 0.61758625 |
| 92 | PRKAA2 | 0.60654911 |
| 93 | ILK | 0.60237798 |
| 94 | PAK3 | 0.59948682 |
| 95 | RPS6KA1 | 0.58956936 |
| 96 | TNK2 | 0.58696715 |
| 97 | RIPK1 | 0.55432126 |
| 98 | PKN1 | 0.54677510 |
| 99 | ROCK1 | 0.54171789 |
| 100 | PDPK1 | 0.53784561 |
| 101 | MTOR | 0.52466652 |
| 102 | PDK4 | 0.51910758 |
| 103 | PDK3 | 0.51910758 |
| 104 | MAPKAPK2 | 0.51397631 |
| 105 | PIK3CA | 0.49121764 |
| 106 | AKT2 | 0.47576287 |
| 107 | CCNB1 | 0.47197511 |
| 108 | BLK | 0.47042564 |
| 109 | MAP2K1 | 0.45494547 |
| 110 | LCK | 0.45147938 |
| 111 | FGFR3 | 0.43662600 |
| 112 | PDK2 | 0.41353046 |
| 113 | FES | 0.41135849 |
| 114 | TLK1 | 0.40917223 |
| 115 | PRKG1 | 0.40898490 |
| 116 | JAK3 | 0.40701498 |
| 117 | PDK1 | 0.39629290 |
| 118 | CAMK2A | 0.39119428 |
| 119 | TGFBR1 | 0.38248759 |
| 120 | HCK | 0.37858534 |
| 121 | MOS | 0.37688478 |
| 122 | PIK3CG | 0.37552275 |
| 123 | MUSK | 0.36994750 |
| 124 | TYK2 | 0.36791373 |
| 125 | SGK3 | 0.36692788 |
| 126 | MARK3 | 0.36030554 |
| 127 | TBK1 | 0.34944820 |
| 128 | ATR | 0.33933384 |
| 129 | ARAF | 0.33520947 |
| 130 | CHEK2 | 0.33494160 |
| 131 | NME1 | 0.33480252 |
| 132 | LIMK1 | 0.33225697 |
| 133 | RAF1 | 0.32901342 |
| 134 | IKBKB | 0.32014632 |
| 135 | MAPK3 | 0.31314060 |
| 136 | DAPK2 | 0.31174791 |
| 137 | GSK3A | 0.30342749 |
| 138 | MAP3K5 | 0.30127671 |
| 139 | SIK1 | 0.29687500 |
| 140 | MAP3K3 | 0.28835445 |
| 141 | MAPK10 | 0.28395996 |
| 142 | PRKACA | 0.28089759 |
| 143 | ROCK2 | 0.27207468 |
| 144 | RPS6KA2 | 0.26254453 |
| 145 | PTK2B | 0.25112062 |
| 146 | RET | 0.24853863 |
| 147 | PTK6 | 0.24670880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Base excision repair_Homo sapiens_hsa03410 | 3.64757796 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.37445332 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.36322263 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.15103110 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.56114354 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.47551736 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.22075737 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.20047232 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 1.97600932 |
| 10 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.86450290 |
| 11 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.76012558 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70963523 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.70543802 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.69550315 |
| 15 | Spliceosome_Homo sapiens_hsa03040 | 1.68631713 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.68096927 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.65462409 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.63044977 |
| 19 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.55605035 |
| 20 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.48328474 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.40775832 |
| 22 | Circadian rhythm_Homo sapiens_hsa04710 | 1.40700054 |
| 23 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.37354483 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35704239 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.32174009 |
| 26 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.31411577 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.29467122 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.29081755 |
| 29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23650152 |
| 30 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.22439600 |
| 31 | Sulfur relay system_Homo sapiens_hsa04122 | 1.22312816 |
| 32 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.21691893 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21592636 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.21215858 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16671302 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.16562999 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15670690 |
| 38 | RNA transport_Homo sapiens_hsa03013 | 1.15186147 |
| 39 | Cell cycle_Homo sapiens_hsa04110 | 1.13751078 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12493504 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01848624 |
| 42 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01119955 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.00223293 |
| 44 | Alzheimers disease_Homo sapiens_hsa05010 | 1.00035215 |
| 45 | Renin secretion_Homo sapiens_hsa04924 | 0.99769444 |
| 46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98361056 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97942983 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.97801862 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.97023246 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93581197 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.93294424 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92315671 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91330773 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 0.90023545 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89552832 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88793062 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86678055 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85623119 |
| 59 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.85447029 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.85200179 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83226383 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82312361 |
| 63 | Measles_Homo sapiens_hsa05162 | 0.82257174 |
| 64 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80970963 |
| 65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.80911534 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.80486223 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80285940 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.79561789 |
| 69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78941946 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.78358304 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.77817965 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.77338480 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76613355 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.76121102 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.75453114 |
| 76 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73864016 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.72243970 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69665951 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68021497 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68004523 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67685136 |
| 82 | Insulin secretion_Homo sapiens_hsa04911 | 0.66874727 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66675796 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65434352 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.65058507 |
| 86 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64802156 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64362566 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.64249258 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64173504 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63902602 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63593064 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.62976864 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62380742 |
| 94 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62098565 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61767775 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60172823 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59090835 |
| 98 | Focal adhesion_Homo sapiens_hsa04510 | 0.58475673 |
| 99 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58456064 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58288922 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56732951 |
| 102 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55914862 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.54781256 |
| 104 | Apoptosis_Homo sapiens_hsa04210 | 0.54175286 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53949969 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52893362 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52189625 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51963334 |
| 109 | Circadian entrainment_Homo sapiens_hsa04713 | 0.51867396 |
| 110 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50863895 |
| 111 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50224073 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49350841 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.48774214 |
| 114 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48479578 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48473444 |
| 116 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47825463 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47763804 |
| 118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46644704 |
| 119 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.46363765 |
| 120 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46278108 |
| 121 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45874720 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44842951 |
| 123 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.44269256 |
| 124 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44066700 |
| 125 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43357454 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42826705 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42744745 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42687715 |
| 129 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41488727 |
| 130 | Olfactory transduction_Homo sapiens_hsa04740 | 0.41411697 |
| 131 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40907340 |
| 132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39859946 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39248243 |
| 134 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38816739 |
| 135 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.38292873 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34280494 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33524445 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32935115 |
| 139 | Amoebiasis_Homo sapiens_hsa05146 | 0.31001267 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27887084 |
| 141 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.25688273 |
| 142 | Huntingtons disease_Homo sapiens_hsa05016 | 0.25409749 |
| 143 | Other glycan degradation_Homo sapiens_hsa00511 | 0.25240205 |
| 144 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.24622683 |
| 145 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.23931319 |
| 146 | Gap junction_Homo sapiens_hsa04540 | 0.23299254 |
| 147 | Glioma_Homo sapiens_hsa05214 | 0.23142880 |
| 148 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.22944931 |
| 149 | Salivary secretion_Homo sapiens_hsa04970 | 0.22760609 |
| 150 | Long-term depression_Homo sapiens_hsa04730 | 0.20341319 |
| 151 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19894480 |
| 152 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.19331292 |

